CS173691A3 - Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy - Google Patents

Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy Download PDF

Info

Publication number
CS173691A3
CS173691A3 CS911736A CS173691A CS173691A3 CS 173691 A3 CS173691 A3 CS 173691A3 CS 911736 A CS911736 A CS 911736A CS 173691 A CS173691 A CS 173691A CS 173691 A3 CS173691 A3 CS 173691A3
Authority
CS
Czechoslovakia
Prior art keywords
formula
group
compounds
solvent
compound
Prior art date
Application number
CS911736A
Other languages
Czech (cs)
English (en)
Inventor
Pascal George
Jacques Menin
Jean-Pierre Merly
Dennis Bigg
Daniel Obitz
Michel Peynot
Corinne Veronique
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of CS173691A3 publication Critical patent/CS173691A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CS911736A 1990-06-07 1991-06-06 Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy CS173691A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007067A FR2663026B1 (fr) 1990-06-07 1990-06-07 Derives de [(1-arylpyrrolidin-2-yl) methyl] piperazine, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
CS173691A3 true CS173691A3 (en) 1992-02-19

Family

ID=9397358

Family Applications (1)

Application Number Title Priority Date Filing Date
CS911736A CS173691A3 (en) 1990-06-07 1991-06-06 Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy

Country Status (21)

Country Link
US (1) US5192763A (pl)
EP (1) EP0461012B1 (pl)
JP (1) JPH04235958A (pl)
KR (1) KR100188902B1 (pl)
AT (1) ATE104662T1 (pl)
AU (1) AU634391B2 (pl)
CA (1) CA2043981A1 (pl)
CS (1) CS173691A3 (pl)
DE (1) DE69101740T2 (pl)
DK (1) DK0461012T3 (pl)
ES (1) ES2054460T3 (pl)
FI (1) FI97055C (pl)
FR (1) FR2663026B1 (pl)
HU (1) HU209620B (pl)
IE (1) IE64688B1 (pl)
IL (1) IL98372A (pl)
NO (1) NO177931C (pl)
NZ (1) NZ238431A (pl)
PL (1) PL165187B1 (pl)
PT (1) PT97885B (pl)
ZA (1) ZA914339B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245712B (it) * 1991-04-09 1994-10-14 Boehringer Mannheim Italia Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree
FR2684374B1 (fr) * 1991-12-02 1995-05-19 Synthelabo Derives substitues de 1-[(1-arylpyrrolidin-2-yl)methyl]piperazine, leur preparation et leur application en therapeutique.
IT1255704B (it) * 1992-09-30 1995-11-10 Boehringer Mannheim Italia Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250771A (en) * 1962-12-17 1966-05-10 Geigy Chem Corp 5-monocarbocyclic aryl-n-lower alkyl-2-pyrrolidine carboxylic acid, esters, amides and derivatives thereof
GB1428493A (en) * 1973-05-02 1976-03-17 Science Union & Cie Heterocyclic amides processes for their preparation and pharma ceutical compositions containing them
US5063242A (en) * 1989-04-21 1991-11-05 Warner-Lambert Company 7-((substituted)amino)-8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agents

Also Published As

Publication number Publication date
NO177931B (no) 1995-09-11
PL290572A1 (en) 1992-02-10
KR100188902B1 (ko) 1999-06-01
DE69101740T2 (de) 1994-10-20
KR920000751A (ko) 1992-01-29
NO177931C (no) 1995-12-20
NO912168L (no) 1991-12-09
EP0461012B1 (fr) 1994-04-20
PT97885A (pt) 1992-03-31
AU7819691A (en) 1991-12-12
ES2054460T3 (es) 1994-08-01
FI912733A0 (fi) 1991-06-06
NZ238431A (en) 1992-09-25
FI97055C (fi) 1996-10-10
IE911941A1 (en) 1991-12-18
FR2663026B1 (fr) 1992-08-07
ZA914339B (en) 1992-03-25
AU634391B2 (en) 1993-02-18
DE69101740D1 (de) 1994-05-26
HUT58070A (en) 1992-01-28
IL98372A0 (en) 1992-07-15
FI97055B (fi) 1996-06-28
US5192763A (en) 1993-03-09
HU209620B (en) 1994-09-28
PL165187B1 (pl) 1994-11-30
FR2663026A1 (fr) 1991-12-13
DK0461012T3 (da) 1994-09-12
IL98372A (en) 1996-01-31
NO912168D0 (no) 1991-06-06
IE64688B1 (en) 1995-08-23
ATE104662T1 (de) 1994-05-15
HU911895D0 (en) 1991-12-30
JPH04235958A (ja) 1992-08-25
CA2043981A1 (en) 1991-12-08
EP0461012A1 (fr) 1991-12-11
FI912733A (fi) 1991-12-08
PT97885B (pt) 1998-10-30

Similar Documents

Publication Publication Date Title
US7335670B2 (en) Derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics
DE60315615T2 (de) Tricyclische verbindungen basierend auf thiophen und arzneimittel, die diese umfassen
PL185029B1 (pl) Nowa 1-(1,2-dwupodstawiona-piperydynylo)-4-podstawiona pochodna piperazyny, kompozycja farmaceutyczna, sposób wytwarzania kompozycji farmaceutycznej i sposób wytwarzania 1-(1,2-dwupodstawionej-piperydynylo)-4-podstawionej pochodnej piperazyny
JP7098663B2 (ja) ピペリジノンホルミルペプチド２受容体アゴニスト
US5210086A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapy
EP0275696B1 (en) Piperidine derivatives
US7928099B2 (en) Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists
JPH0283375A (ja) ２−置換ピペラジニル−２−（１，２−ベンズイソキサゾール−３−イル）酢酸誘導体
CA2354213C (en) N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity
AU705683B2 (en) Piperazino derivatives as neurokinin antagonists
AU680626B2 (en) 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract
EA008148B1 (ru) Новые соединения, их применение и получение
US5166156A (en) Naphthyl piperazines useful as 5-HT1A receptor ligands
CS173691A3 (en) Derivatives of /(1-arylpyrrolidin-2-yl)methyl/piperazine, process for their preparation and their use in therapy
DE602004004550T2 (de) Substituierte heterocyclische verbindungen und anwendungsverfahren
KR101771794B1 (ko) 트리아졸로-아릴아크릴로나이트라일 유도체 및 이의 용도
US5066651A (en) Pyrrolidone compounds for treating cerebral disorders
EP0325984A2 (en) 5-substituted 1-/4-(1-pyrrolidinyl)-2-butynyl/-2-pyrrolidones and related compounds, a process for their preparation and their use as medicaments
IE900027L (en) New bis(aryl)alkene derivatives, processes for preparing¹them and pharmaceutical compositions containing them
US5166157A (en) Naphthyl piperazines useful as 5-HT1A receptor ligands
US5068231A (en) Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
US5183902A (en) Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
US5162321A (en) 1-naphthyl piperazines useful as 5-HT1A receptor ligands
US5151418A (en) Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
US5162324A (en) Naphyl piperazines useful as 5-HT1A receptor ligands